Boston Scientific Corporation (BSX) Q4 2022 Earnings Call Transcript

Boston Scientific Corporation (NYSE:BSX) Q4 2022 Results Conference Call February 1, 2023 8:00 AM ET

Company Participants

Lauren Tengler - Vice President, Investor Relations
Mike Mahoney - Chairman & Chief Executive Officer
Dan Brennan - Executive Vice President & Chief Financial Officer
Ken Stein - Chief Medical Officer

Conference Call Participants

Rick Wise - Stifel
Robbie Marcus - JPMorgan
Larry Biegelsen - Wells Fargo
Joanne Wuensch - Citi
Vijay Kumar - Evercore ISI
Travis Steed - Bank of America
Cecilia Furlong - Morgan Stanley
Josh Jennings - Cowen

Operator

Good morning, and welcome to the Boston Scientific Fourth Quarter 2022 Earnings Call. All participants will be in listen only mode [Operator Instructions] Please note, this event is being recorded.

I would now like to turn the conference over to Lauren Tengler, Vice President, Investor Relations. Please go ahead.

Lauren Tengler

Thank you, Drew. Welcome, everyone, and thanks for joining us today. With me on today's call are Mike Mahoney, Chairman and Chief Executive Officer; and Dan Brennan, Executive Vice President and Chief Financial Officer.

We issued a press release earlier this morning announcing our Q4 and full year '22 results, which includes reconciliations of the non-GAAP measures used in the release. We have posted a copy of that release as well as reconciliations of the non-GAAP measures used in today's call to the Investor Relations section of our website under the heading Financials and Filings. The duration of this morning's call will be approximately one hour.

Mike and Dan will provide comments on Q4 and full year performance as well as the outlook for our business, including 2023 guidance, and then we'll take your questions. During today's Q&A session, Mike and Dan will be joined by our Chief Medical Officer, Dr. Ian Meredith and Dr. Ken Stein.

Before we begin, I'd